SFX by Ex Libris Inc.

Title:	Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus
Source:	Journal of Medicinal Chemistry [0022-2623] Roth, Bruce yr:1991

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	SLISKOVIC, D. "INHIBITORS OF CHOLESTEROL-BIOSYNTHESIS .2. 1,3,5-TRISUBSTITUTED [2-(TETRAHYDRO-4-HYDROXY-2-OXOPYRAN-6-YL)ETHYL]PYRAZOLES." Journal of medicinal chemistry 33.1: 31-38.
description	2.	STOKKER, G. "3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE INHIBITORS .3. 7-(3,5-DISUBSTITUTED [1,1'-BIPHENYL]-2-YL)-3,5-DIHYDROXY-6-HEPTENOIC ACIDS AND THEIR LACTONE DERIVATIVES." Journal of medicinal chemistry 28.3: 170-181.
description	3.	McKenzie, T C. "5-Aryl-3-azabicyclo[3.2.0]heptan-6-one ketals, compounds with morphine-like analgesic activity." Journal of medicinal chemistry 27.5 (1984): 628-33.
description	4.	KRAUSE, Brian R. "LIPID-LOWERING ACTIVITY OF ATORVASTATIN AND LOVASTATIN IN RODENT SPECIES - TRIGLYCERIDE-LOWERING IN RATS CORRELATES WITH EFFICACY IN LDL ANIMAL-MODELS." Atherosclerosis 117.2 (1995): 237-244.
description	5.	Sammes, Michael P. "The synthesis and chemistry of azolenines. Part 4. Preparation and rearrangement of some 3,5-diaryl-2H-pyrrole-2,2-dicarboxylic esters." Journal of the Chemical Society. Perkin transactions 1 8 (1985): 1773-1779.
description	6.	Roth, Bruce D. "Synthesis of a chiral synthon for the lactone portion of compactin and mevinolin." Tetrahedron letters; 29.11 (1988): 1255-1258.
description	7.	Chan, C. "Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of 3-hydroxy-3-methylglutarate-CoA reductase inhibitors." Journal of medicinal chemistry 36.23 (1993): 3646-373.
description	8.	Terent'ev, Alexander O. "Synthesis of Asymmetric Peroxides: Transition Metal (Cu, Fe, Mn, Co) Catalyzed Peroxidation of ÃÂ²-Dicarbonyl Compounds with tert-Butyl Hydroperoxide." Journal of organic chemistry 75.15 (2010): 5065-5071.
description	9.	Stauffer, S. R. "Estrogen pyrazoles: defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor." Bioorganic & medicinal chemistry 9.1 (2001): 141-150.
description	10.	Horton, W. J. "Seven-membered ring compounds. X. Hydroxy- and methoxybenzosuberones." Journal of organic chemistry 25 (1960): 131-.
description	11.	Kim, Dong Wook W. "Significantly enhanced reactivities of the nucleophilic substitution reactions in ionic liquid." Journal of organic chemistry 68.11 (2003): 4281-4285.
description	12.	Leber, P. "Slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase." Biochemistry 29.17 (1990): 4115-20.
description	13.	Hoffman, W F F. "3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin." Journal of medicinal chemistry 29.5 (1986): 849-52.
description	14.	Hudlicky, T. "Recent chemoenzymatic total syntheses of natural and unnatural products: Codeine, balanol, pancratistatin, and oseltamivir." Pure and applied chemistry 82.9 (2010): 1785-1796.
description	15.	CHAO, YS. "EFFECTS OF CHOLESTYRAMINE ON LOW-DENSITY LIPOPROTEIN BINDING-SITES ON LIVER MEMBRANES FROM RABBITS WITH ENDOGENOUS HYPERCHOLESTEROLEMIA INDUCED BY A WHEAT STARCH-CASEIN DIET." The Journal of biological chemistry (1982): 3623-3627.
description	16.	KNIGHT, David W. "A general approach to polysubstituted pyrroles." Tetrahedron Letters 48.44 (2007): 7906-7910.
description	17.	Endo, A. "The discovery and development of HMG-CoA reductase inhibitors." Journal of lipid research 33.11 (1992): 1569-82.
description	18.	Stern, S C H. "Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor." The Journal of clinical pharmacology 40.6 (2000): 616-23.
description	19.	NAWROCKI, J. "REDUCTION OF LDL CHOLESTEROL BY 25-PERCENT TO 60-PERCENT IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA BY ATORVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR." Arteriosclerosis, thrombosis, and vascular biology 15.5 (1995): 678-682.
description	20.	Crisp, Geoffrey T. "Conjugate addition of amino acid side chains to dyes containing alkynone, alkynoic ester and alkynoic amide linker arms." Tetrahedron 54.3 (1998): 649-666.